Grifols (GRFS) Free Cash Flow (2009 - 2026)
Grifols (GRFS) free cash flow from Dec 31, 2009 to Mar 31, 2026. The TTM Grifols (GRFS) free cash flow is $873M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Grifols (GRFS) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -12.75% |
| 5 Years TTM | -4.02% |
| 10 Years TTM | +4.91% |
Annual Free Cash Flow change of Grifols (GRFS)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $68M | -92.28% |
| 2025 | $882M | +60.55% |
| 2024 | $549M | -643.00% |
| 2023 | -$101M | -75.45% |
| 2022 | -$412M | -228.64% |
| 2021 | $320M | -64.92% |
| 2020 | $913M | +420.07% |
| 2019 | $176M | -64.36% |
| 2018 | $493M | -20.95% |
| 2017 | $623M | +128.60% |
| 2016 | $273M | +42.85% |
| 2015 | $191M | -77.20% |
| 2014 | $837M | +45.30% |
| 2013 | $576M | +28.04% |
| 2012 | $450M | +476.57% |
| 2011 | $78M | +6757.44% |
| 2010 | $1.14M | -102.60% |
| 2009 | -$44M | -142.72% |
| 2008 | $103M | -20.66% |
| 2007 | $129M | N/A |
Comparison Grifols (GRFS) five years free cash flow CAGR with competitors
Grifols (GRFS) five years free cash flow CAGR is -4.02%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | 21.25% | -629.12% |
| AZN | Astrazeneca plc | 18.52% | -561.09% |
| NVS | Novartis AG | 9.71% | -341.75% |
| SNY | Sanofi | 8.08% | -301.28% |
| MRK | Merck & Co Inc | 5.49% | -236.69% |
| GILD | Gilead Sciences Inc | 3.30% | -182.11% |
| ABBV | Abbvie Inc | 2.35% | -158.52% |